

Founded in 2020, Lillia operates in Health Tech offering a clinically proven, AI-powered platform that enables healthcare providers, insurers, and corporations to manage chronic diseases effectively. ...
Funding stage:
Grant
Last funding:
23/02/2025
Total funding:
$1.70 Mn+
Investors
Web traffic:
1.67K
1.67K
Last 30d
Last 30d
Lillia: Cap Table Highlights
A snapshot of cap table and shareholder metrics
- Total Shareholders18
- Latest Filing Date04 Aug 2024
- Funding Events1
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Lillia
As of 05 August 2024, Lillia's equity is held by 16 shareholders, with the top three being Sujit Chakrabarty, Trio Investments LLC, and Abdulla Almisnad.
Sujit Chakrabarty holds the largest stake in Lillia at 34.1% as of 05 August 2024.
As of 05 August 2024, founders collectively hold 34.1% equity in Lillia.
As of 05 August 2024, investors collectively hold 42.9% equity in Lillia.
Lillia's ESOP pool stands at 4.1% of total equity as of 05 August 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links